BioMed X, a pharmaceutical innovation hub, is partnering with the government of Barbados on research for AI-enabled therapy.
BioMed X, a leading innovation hub for pharma, has announced the launch of its first research project in partnership with the Government of Barbados and with support from the European Union’s ...
Texas Biomed expanding work — and revenue base — with Big Pharma; seen as key to its competitiveness
Before the COVID-19 pandemic, Texas Biomedical Research Institute had established itself as a go-to researcher of infectious diseases, along with therapeutics and vaccines to combat them. It was ...
German research institute BioMed X and Ono Pharmaceutical, a Japanese pharmaceutical company, started a new joint research project on cancer immunotherapies. HEIDELBERG, GERMANY / ACCESSWIRE / ...
Traditionally, medtech companies have utilized a sales-based model, but many of them are now transitioning to recurring-revenue models like subscription-based services or device-as-a-service. The need ...
Harbour BioMed announced its wholly owned subsidiary is exercising a warrant agreement to acquire common stock in Spruce ...
Dublin, Jan. 06, 2026 (GLOBE NEWSWIRE) -- The "The Applications of Nanoparticles in the Pharmaceutical and Biomedical Industries Training Course (Mar 11th - Mar 12th, 2026)" training has been added to ...
NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies ...
USC and the Alfred E. Mann Foundation for Biomedical Engineering have launched a major initiative to reimagine biomedical engineering and pharmaceutical sciences for the 21st century. A gift from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results